e-learning
resources
Vienna 2009
Monday, 14.09.2009
Severe asthma and its treatment
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Leptin as a specific marker of risk factors in severe bronchial asthma
V. Mineev, L. Sorokina, V. Berestovskaya, M. Nyoma, V. Trofimov (Saint-Petersburg, Russian Federation)
Source:
Annual Congress 2009 - Severe asthma and its treatment
Session:
Severe asthma and its treatment
Session type:
E-Communication Session
Number:
1861
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
V. Mineev, L. Sorokina, V. Berestovskaya, M. Nyoma, V. Trofimov (Saint-Petersburg, Russian Federation). Leptin as a specific marker of risk factors in severe bronchial asthma. Eur Respir J 2009; 34: Suppl. 53, 1861
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
BRUNO Andreina - 14.09.2009 14:26
Categorie of asthmatic patients
Interesting work. Which kind of severe asthma affected the patients enrolled? Neutrofilic or eosinophilic asthma?
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Severe bronchial asthma: risk factors
Source: Annual Congress 2008 - Allergy and immunology of asthma and beyond
Year: 2008
High BMI in severe asthma is associated with co-morbid factors but not with increased airway inflammation or -obstruction
Source: Eur Respir J 2002; 20: Suppl. 38, 406s
Year: 2002
Increased bronchial hyperreactivity (BHR) in sarcoidosis patients maybe a risk factor for progression of the disease
Source: Annual Congress 2009 - Sarcoidosis and profiles of other diffuse parenchymal lung disease
Year: 2009
Upregulation of interleukin-19 in severe asthma: a potential saliva biomarker for asthma severity
Source: ERJ Open Res, 7 (3) 00984-2020; 10.1183/23120541.00984-2020
Year: 2021
Smoking and concomitant medication as risk factors for exacerbation of bronchial asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 45s
Year: 2005
Allergic rhinitis co-morbidity as risk factor on lung function parameters recovery after asthma exacerbation
Source: International Congress 2019 – Epidemiology of childhood respiratory diseases
Year: 2019
Chronic bronchitis, asthma and rhinitis are differently associated with cardiovascular risk factors and diseases.
Source: International Congress 2017 – Asthma epidemiology among children and adults: from biomarkers to ACOS
Year: 2017
The risk factors contributing asthma development in children
Source: Eur Respir J 2002; 20: Suppl. 38, 144s
Year: 2002
Individual allergens as risk factors for asthma and bronchial hyperresponsiveness in Chinese children
Source: Eur Respir J 2001; 18: Suppl. 33, 452s
Year: 2001
Evaluation and management of difficult-to-control asthma
Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside
Year: 2007
Prevalence and risk factors of fixed airway obstruction in children with asthma
Source: International Congress 2018 – The bad and the ugly in paediatric asthma: comorbidities and exacerbations
Year: 2018
Airway hyperresponsiveness and smoking, but not atopy, are associated with moderate and severe-persistent respiratory disease: analysis of a longitudinal birth cohort
Source: Annual Congress 2005 - Highlights of asthma epidemiology
Year: 2005
Are asymptomatic airway hyperresponsiveness and allergy risk factors for asthma? A longitudinal study
Source: Eur Respir J 2009; 33: 218-219
Year: 2009
Interleukin-10 polymorphisms influence the neonatal immune response and may be a risk factor for childhood allergic disease and wheeze
Source: Annual Congress 2011 - Inflammation and genes in childhood asthma
Year: 2011
Risk factors for severe asthma among adults with asthma
Source: Virtual Congress 2020 – Diagnosis and management of asthma
Year: 2020
Exacerbations in severe persistent asthma - impact of risk factors control
Source: Eur Respir J 2005; 26: Suppl. 49, 683s
Year: 2005
Prediction of the risk of future exacerbations in patients with severe persistent allergic asthma
Source: Annual Congress 2005 - Severe asthma: perception and management
Year: 2005
Increased serum IL-17 is an independent risk factor for severe asthma
Source: Annual Congress 2008 - Severe asthma: a heterogeneous clinical entity
Year: 2008
The risk of cardiovascular disease associated with asthma may be mediated by short-acting β
2
-agonists
Source: Annual Congress 2008 - Epidemiology of asthma and allergy
Year: 2008
Specific comorbidities and low adherence are independent risk factors for poorer asthma control and exacerbations in patients with difficult-to-control asthma
Source: International Congress 2019 – Long-term evaluation and control of airway diseases
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept